The role of health economics in the Stand Together trial: evaluating the cost-effectiveness of KiVa in UK primary schools

Holly Whiteley; Rhiannon Tudor Edwards

Crynodeb

We conducted a health economic evaluation of the KiVa anti-bullying programme, alongside the Stand Together trial, to explore its cost-effectiveness for reducing bullying amongst 7-to-11-year-olds in UK primary schools.

Our presentation will outline the importance of health economics in contributing to the evidence-base for the KiVa programme and will introduce our approach and methods for costing and evaluating KiVa compared to usual practice.

Cost calculations were conducted from an education-sector perspective and included KiVa training and resources plus staff-time preparing and delivering lessons. The estimated costs of KiVa and usual practice will be used in three separate health economic analyses to explore cost-effectiveness;
i) a cost-utility analysis exploring the incremental cost of KiVa per incremental pupil-reported quality-adjusted life year (QALY) gained,
ii) a cost-effectiveness analysis exploring the incremental cost per incremental bullying incident avoided (BIA),
iii) a cost-consequence analysis comparing costs with a wide range of pupil- and teacher outcomes.

Iaith wreiddiol	Saesneg
Statws	Cyhoeddwyd - Maw 2024
Digwyddiad	Why Bullying Prevention in School Matters: Centre for Evidence Based Early Intervention - Bangor University, Bangor, Y Deyrnas Unedig Hyd: 20 Maw 2024 → 20 Maw 2024

Cynhadledd

Cynhadledd	Why Bullying Prevention in School Matters
Gwlad/Tiriogaeth	Y Deyrnas Unedig
Dinas	Bangor
Cyfnod	20/03/24 → 20/03/24

NDC y CU

Mae’r allbwn hwn yn cyfrannu at y Nod(au) Datblygu Cynaliadwy canlynol

NDC 3 Iechyd a Llesiant Da

Dyfynnu hyn

@conference{5d3f872cada0490e82bab8c72e6754a7,

title = "The role of health economics in the Stand Together trial: evaluating the cost-effectiveness of KiVa in UK primary schools",

abstract = "We conducted a health economic evaluation of the KiVa anti-bullying programme, alongside the Stand Together trial, to explore its cost-effectiveness for reducing bullying amongst 7-to-11-year-olds in UK primary schools. Our presentation will outline the importance of health economics in contributing to the evidence-base for the KiVa programme and will introduce our approach and methods for costing and evaluating KiVa compared to usual practice. Cost calculations were conducted from an education-sector perspective and included KiVa training and resources plus staff-time preparing and delivering lessons. The estimated costs of KiVa and usual practice will be used in three separate health economic analyses to explore cost-effectiveness; i) a cost-utility analysis exploring the incremental cost of KiVa per incremental pupil-reported quality-adjusted life year (QALY) gained, ii) a cost-effectiveness analysis exploring the incremental cost per incremental bullying incident avoided (BIA), iii) a cost-consequence analysis comparing costs with a wide range of pupil- and teacher outcomes. ",

author = "Holly Whiteley and Edwards, \{Rhiannon Tudor\}",

year = "2024",

month = mar,

language = "English",

note = "Why Bullying Prevention in School Matters : Centre for Evidence Based Early Intervention ; Conference date: 20-03-2024 Through 20-03-2024",

}

TY - CONF

T1 - The role of health economics in the Stand Together trial: evaluating the cost-effectiveness of KiVa in UK primary schools

AU - Whiteley, Holly

AU - Edwards, Rhiannon Tudor

PY - 2024/3

Y1 - 2024/3

N2 - We conducted a health economic evaluation of the KiVa anti-bullying programme, alongside the Stand Together trial, to explore its cost-effectiveness for reducing bullying amongst 7-to-11-year-olds in UK primary schools. Our presentation will outline the importance of health economics in contributing to the evidence-base for the KiVa programme and will introduce our approach and methods for costing and evaluating KiVa compared to usual practice. Cost calculations were conducted from an education-sector perspective and included KiVa training and resources plus staff-time preparing and delivering lessons. The estimated costs of KiVa and usual practice will be used in three separate health economic analyses to explore cost-effectiveness; i) a cost-utility analysis exploring the incremental cost of KiVa per incremental pupil-reported quality-adjusted life year (QALY) gained, ii) a cost-effectiveness analysis exploring the incremental cost per incremental bullying incident avoided (BIA), iii) a cost-consequence analysis comparing costs with a wide range of pupil- and teacher outcomes.

AB - We conducted a health economic evaluation of the KiVa anti-bullying programme, alongside the Stand Together trial, to explore its cost-effectiveness for reducing bullying amongst 7-to-11-year-olds in UK primary schools. Our presentation will outline the importance of health economics in contributing to the evidence-base for the KiVa programme and will introduce our approach and methods for costing and evaluating KiVa compared to usual practice. Cost calculations were conducted from an education-sector perspective and included KiVa training and resources plus staff-time preparing and delivering lessons. The estimated costs of KiVa and usual practice will be used in three separate health economic analyses to explore cost-effectiveness; i) a cost-utility analysis exploring the incremental cost of KiVa per incremental pupil-reported quality-adjusted life year (QALY) gained, ii) a cost-effectiveness analysis exploring the incremental cost per incremental bullying incident avoided (BIA), iii) a cost-consequence analysis comparing costs with a wide range of pupil- and teacher outcomes.

M3 - Abstract

T2 - Why Bullying Prevention in School Matters

Y2 - 20 March 2024 through 20 March 2024

ER -

The role of health economics in the Stand Together trial: evaluating the cost-effectiveness of KiVa in UK primary schools

Crynodeb

Cynhadledd

NDC y CU

Ôl bys

Dyfynnu hyn